Answers are grounded in this paper and cite their sources.
Bladder preservation presents an attractive option for patients with muscle invasive bladder cancer due to surgical and postsurgical complications associated with radical cystectomy. Bladder preservation is accomplished with a multidisciplinary approach known as trimodality therapy, incorporating maximal transurethral resection of the bladder tumor, radiation, and chemotherapy. Trimodality therapy has similar efficacy to radical cystectomy in retrospective studies, but randomized studies between the two modalities failed to accrue enough patients. Financially, trimodality therapy has been less cost-effective, but optimization of efficacy and standardization of surveillance procedures may better this. Recent advances incorporating immunotherapy, antibody-drug conjugates, and biomarkers may improve outcomes.
No takes yet. Share an insight, caveat, or question.
Carsel et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: